Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention

Clinica Chimica Acta

Volumn 435, Issue , 2014, Pages 48-52

  Padhy, Mamta ^a   Kaushik, Smita ^a   Girish, M P ^b   Mohapatra, Sudhesna ^a   Shah, Seema ^a   Koner, Bidhan Chandra ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

Acute kidney injury; Angiography; Cystatin C; NGAL

Indexed keywords

CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; ADULT; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84901022665     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.04.016     Document Type: Article

References (44)

1. Nash K., Hafeez A., Hou S. Hospital acquired renal insufficiency. Am J Kidney Dis 2002, 39:930-936.
2. McCullough P.A., Adam A., Beeker C.R., et al. CIN consensus working panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006, 5k-13k. (Suppl.).
3. Waybill M.M., Waybill P.N. Contrast-media induced nephrotoxicity, identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001, 12:3-9.
4. Solomon R. Contrast media nephropathy-how to diagnose and how to prevent?. Nephrol Dial Transplant 2007, 22:1812-1815.
5. Detrenis S., Meschi M., Musini S., Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy, state of the art. Nephrol Dial Transplant 2005, 20:1542-1550.
6. Thomsen H.S., Morcos S.K. Contrast media and the kidney. European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003, 76:513-518.
7. Shaker O., El-Shehaby A., El-Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology 2010, 61:731.
8. Dalton R.N. Serum creatinine and glomerular filtration rate: perception and reality. Clin Chem 2010, 56:687-689.
9. Pottel H., Martens F. Are eGFR equations better than IDMS-traceable serum creatinine in classifying chronic kidney disease?. Scand J Clin Lab Invest 2009, 69(5):550-561.
10. Devrajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 2007, 156:203-212.
11. Mishra J., Ma Q., Prada A., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14(10):2534-2543.
12. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL), a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004, 24(3):307-315.
13. Mori K., Lee H.T., Rapoport D., et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005, 115(3):610-621.
14. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
15. Hirsch R., Dent C., Pfriem H., et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007, 22:2089-2095.
16. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., Malyszko J.S., Dobrzycki S. Neutrophil gelatinase associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006, 26:287-292.
17. Parikh C.R., Jani A., Mishra J., et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006, 6(7):1639-1645.
18. Shlipak M.G., Ix J.H., Bibbins-Domingo K., et al. Biomarkers to predict recurrent cardiovascular disease, the Heart and Soul Study. Am J Med 2008, 121(1):50-57.
19. Kato K., Sato N., Yamamoto T., Iwasaki Y.K., Tanaka K., Mizuno K. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization. Circ J 2008, 72(9):1499-1505.
20. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., et al. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C, are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?. Int J Cardiol 2008, 127(2):290-291.
21. Ishibash Y., Yamauchi M., Musha H., Mikami T., Kawasaki K., Miyake F. Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization. Angiology 2010, 61(8):724-730.
22. Pannu N., Wiebe N., Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006, 295:2765-2779.
23. Solomon R.J., Mehran R., Natarajan M.K., et al. Contrast-induced nephropathy and long-term adverse events: cause and effect?. Clin J Am Soc Nephrol 2009, 4(7):1162-1169.
24. Fehr T., Rickli H. Reply to Sjostrom et al. cystatin C and creatinine for assessment of kidney function: differences in pharmacokinetics-and more. Clin Nephrol 2004, 62(4):327-328.
25. Rickli H., Benou K., Ammann P., et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 2004, 61(12):98-102.
26. Stevens L.A., Schmid C.H., Greene T., et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009, 75(6):652-660.
27. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
28. Abramson J.L., Weintraub W.S., Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002, 39(2):197-202.
29. Hoek F.J., Kemperman F.A., Krediet R.T. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003, 18:2024-2031.
30. Bellomo R., Kellum J.A., Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004, 30(1):33-37.
31. Murphy S.W., Barrett B.J., Parfrey P.S. Contrast nephropathy. J Am Soc Nephrol 2000, 1:177-182.
32. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006, 17:1503-1520.
33. Torregrosa I., Montoliu C., Urios A., et al. Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure. Nefrologia 2012, 32(1):44-52.
34. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A., NGAL Meta-analysis Investigator Group Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54(6):1012-1024.
35. Mishra J., Mori K., Ma Q., et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase associated lipocalin. J Am Soc Nephrol 2004, 15:3073-3082.
36. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore mediated iron acquisition. Mol Cell 2002, 10:1033-1043.
37. Schmidt-Ott K.M., Mori K., Li J.Y., et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007, 18:407-413.
38. Flo T.H., Smith K.D., Sato S., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestering iron. Nature 2004, 432:917-921.
39. Briguori C., Visconti G., Rivera N.V., et al. Cystatin C and contrast-induced acute kidney injury. Circulation 2010, 121:2117-2122.
40. Newman D.J., Thakkar H., Edwards R.G., et al. Serum cystatin C measured by automated immunoassay. A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995, 47:312-318.
41. Abrahamson M., Olafsson I., Palsdottir A., et al. Structure and expression of the human cystatin C gene. Biochem J 1990, 268:287-294.
42. Westhuyzen J. Review cystatin C, a promising marker and predictor of impaired renal function. Ann Clin Lab Sci 2006, 36(4):387-394.
43. Conti M., Moutereau S., Zater M., et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 2006, 44:288-291.
44. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., et al. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?. Kidney Blood Press Res 2007, 30(6):408-415.